Presentation
Press Release
Creating a Global Biotechnology Company and Leader in Rare Diseases
Shire 2016 Investor Day
20 x 20: Creating the Global Leader in Rare Diseases
Shire to acquire NPS Pharmaceuticals
Shire to acquire Dyax Corp.
Takeda’s most recent quarterly results and relevant reports
Press release announcing completion of acquisition of Shire plc
